Literature DB >> 20573370

Prognostic impact of blood vessel invasion in gastrointestinal stromal tumor of the stomach.

Hidetaka Yamamoto1, Aya Kojima, Yoshihiro Miyasaka, Masakazu Imamura, Norimoto Nakamura, Takashi Yao, Masazumi Tsuneyoshi, Yoshinao Oda.   

Abstract

Gastrointestinal stromal tumors have a wide spectrum of biologic behavior, and occasional cases show liver metastases. The modified risk grade based on tumor size and mitotic counts has been proposed to predict the biologic behavior in gastric gastrointestinal stromal tumors. Blood vessel invasion (BVI) is important in the development of metastasis of various kinds of cancer. The aim of this study was to elucidate the potential role of blood vessel invasion in gastric gastrointestinal stromal tumors. Blood vessel invasion was found in 17 of 122 cases (13.9%) of gastrointestinal stromal tumors, and was significantly correlated with larger tumor size, higher mitotic count and higher modified risk grade. Among 83 cases of primary, localized gastric gastrointestinal stromal tumors available for follow-up information, liver metastasis was observed in 14 cases (16.9%). When blood vessel invasion was positive in the primary tumor, liver metastasis occurred in 80% of cases after the initial surgery, indicating that blood vessel invasion was a significant risk factor of liver metastasis (P < .0001). In univariate and multivariate analyses, tumor size (>5 cm), mitotic count (>5/50 high-power fields) and blood vessel invasion (positive) were significantly associated with a shorter period of disease-free survival. Our results suggest that the evaluation of blood vessel invasion may be useful for predicting the risk of liver metastasis and aggressive biologic behavior of gastrointestinal stromal tumors, and may serve as important information for determining the therapeutic strategies including adjuvant molecular target therapy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573370     DOI: 10.1016/j.humpath.2010.02.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft.

Authors:  Tian-bao Wang; Xiu-qing Wei; Wei-hao Lin; Han-ping Shi; Wen-guang Dong
Journal:  Clin Exp Med       Date:  2011-06-10       Impact factor: 3.984

2.  Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour.

Authors:  Cuiping Zhou; Xiaohui Duan; Xiang Zhang; Huijun Hu; Dongye Wang; Jun Shen
Journal:  Eur Radiol       Date:  2015-12-23       Impact factor: 5.315

3.  Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors.

Authors:  Qinggang Hu; Shanglong Liu; Jianwei Jiang; Chen Zhang; Xiaowei Liu; Qichang Zheng
Journal:  Front Med       Date:  2012-07-14       Impact factor: 4.592

4.  KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors.

Authors:  Yoshiyuki Suehara; Keisuke Akaike; Kenta Mukaihara; Aiko Kurisaki-Arakawa; Daisuke Kubota; Taketo Okubo; Hiroyuki Mitomi; Keiko Mitani; Michiko Takahashi; Midori Toda-Ishii; Youngji Kim; Yu Tanabe; Tatsuya Takagi; Takuo Hayashi; Kaoru Mogushi; Kazuo Kaneko; Takashi Yao; Tsuyoshi Saito
Journal:  Oncotarget       Date:  2018-06-05

Review 5.  Gastrointestinal Stromal Tumors of the Small Intestine: Progress in Diagnosis and Treatment Research.

Authors:  Fangxing Peng; Yao Liu
Journal:  Cancer Manag Res       Date:  2020-05-25       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.